Understanding stem cell therapy — a primer.
The plain-language version of stem cell therapy — what it actually is, how it works, where the cells come from, and what the published evidence does and doesn't support. Start here if you're new to all this.
Read the primer
Science
How stem cells actually work — replace, renew, signal.
Why paracrine signalling — not direct cell replacement — is now considered the main mechanism. With citations to Caplan 1991, 2011, and 2017.
Read article
Safety
Is stem cell therapy safe? What the data actually shows.
A close look at the published safety record across major MSC trials, the four real risk factors, and how to evaluate a clinic. Citations: Lalu 2012, Thompson 2020, NEJM.
Read article
Cost
How much does stem cell therapy actually cost?
A transparent 2026 breakdown for Singaporeans — autologous in Tokyo, allogeneic in Kuala Lumpur, and the extras most clinics don't disclose.
Read article
Protocol
Autologous vs allogeneic — which protocol fits which person.
A practical, cited decision framework on biology, age, time, cost, and lifestyle. How to think about Tokyo versus Kuala Lumpur.
Read article
Conditions
Stem cell therapy for knee pain & osteoarthritis.
What the published RCTs actually show on MSC injections for knee OA — pain, function, and what's realistic versus what's hype.
Read article
Regulation
Is stem cell therapy FDA approved? A 2026 regulatory guide.
What the FDA actually approves vs what's marketed, and how Japan, Malaysia, and Singapore regulate cell therapy differently.
Read article
Conditions
Stem cell therapy for type 2 diabetes.
What the RCTs actually show on MSC therapy for T2D — HbA1c, C-peptide preservation, insulin reduction — and where the evidence is honest about its limits.
Read articleCurious about your own protocol?
Speak with our team about whether autologous (Tokyo) or allogeneic (Kuala Lumpur) is the right fit. No obligation — just a clear conversation.
Schedule a consultation